Skip to content

Icosagen Cell Factory OÜ

Registry code (registrikood) 11107818Private limited company (Osaühing)VAT EE100969520Activity (EMTAK 72101): Teadus- ja arendustegevus loodus- ja tehnikateaduste vallasActive

Kambja vald, Tartu County · Financial data: annual reports up to 2025; tax data up to 2026 Q2

Revenue (2025)
€8.8M
▼ 32.1% vs 2024
Profit before tax (2025)
-€4.4M
Employees, FTE (2025)
182
State taxes paid, last 4 quarters
€3.4M

Revenue, profit and employees, 2019–2025

€4.8M2019€6.7M2020€11.5M2021€13.7M2022€13.3M2023€12.9M2024€8.8M2025
YearRevenue (müügitulu)Operating profit (ärikasum)Net profitEquity (omakapital)Employees, FTE
2019€4,767,928€728,698€704,429€2,134,92444
2020€6,679,291€1,796,836€1,743,876€3,878,80050
2021€11,485,743€5,300,125€5,332,983€9,211,78367
2022€13,677,072€5,942,204€5,967,760€15,179,543102
2023€13,347,905€2,593,167€2,475,854€17,655,397134
2024€12,916,070€1,143,258€848,033€18,503,430167
2025€8,771,543-€3,803,823-€4,384,364€14,119,066182

Balance sheet summary

YearCashTotal assetsCurrent liabilitiesNon-current liabilitiesEquity
2019€1,432,090€3,775,075€899,155€740,996€2,134,924
2020€1,978,330€5,793,374€1,163,024€751,550€3,878,800
2021€6,535,752€11,683,832€1,919,486€552,563€9,211,783
2022€7,774,235€19,612,178€3,453,448€979,187€15,179,543
2023€2,121,424€23,727,980€5,663,753€408,830€17,655,397
2024€4,458,871€30,566,808€4,504,353€7,559,025€18,503,430
2025€4,465,049€38,484,883€5,535,535€18,830,282€14,119,066

Calculated ratios

Net profit margin = net profit ÷ revenue. Equity ratio = equity ÷ total assets. Seedata sources & methodology for how each figure is derived.

Quarterly tax and turnover data (EMTA)

QuarterState taxes paidWage taxesTurnoverEmployees
2022 Q1€365,682€389,743€4,851,32194
2022 Q2€373,636€349,548€3,935,976108
2022 Q3€391,344€414,445€3,938,824116
2022 Q4€399,992€423,703€4,133,718119
2023 Q1€604,233€640,958€5,570,616134
2023 Q2€577,252€538,385€4,708,062140
2023 Q3€551,505€588,218€4,758,861148
2023 Q4€569,189€599,328€7,583,415157
2024 Q1€801,431€852,031€5,879,468170
2024 Q2€679,998€727,184€5,118,360170
2024 Q3€746,582€791,527€3,632,695175
2024 Q4€695,022€744,389€4,547,083184
2025 Q1€967,790€1,039,450€4,591,710190
2025 Q2€876,606€946,108€2,949,098184
2025 Q3€878,797€948,072€2,995,432183
2025 Q4€853,065€920,170€2,917,425180
2026 Q1€841,560€911,298€4,171,962185
2026 Q2€859,116€936,603€3,951,657176

Source: EMTA quarterly published data, as of 10 July 2026. Covers state taxes and wage taxes actually paid and turnover and employee counts as declared by the company, not the annual report figures above.

About this data

In the 2025 financial year (period 1 January 2025–31 December 2025), Icosagen Cell Factory OÜ reported revenue of €8,771,543.

The company recorded a net loss of €4,384,364 in the 2025 financial year.

Revenue decreased by 32.1% from €12,916,070 in 2024 to €8,771,543 in 2025.

Revenue grew at a compound annual rate of 10.7% between 2019 and 2025.

Equity accounted for 36.7% of total assets of €38,484,883 at the end of the 2025 reporting period.

With 182 full-time-equivalent employees in 2025, revenue per employee was €48,195.

Across the 4 most recent quarters declared to EMTA, up to Q2 2026, Icosagen Cell Factory OÜ reported €14,036,476 in turnover.

EMTA recorded 176 employees for the quarter ending Q2 2026, compared with 182 full-time-equivalent employees in the 2025 annual report.

Browse

Source

Source: Estonian e-Business Register open data (Centre of Registers and Information Systems, RIK), licence CC BY-SA 4.0, modified; Estonian Tax and Customs Board (EMTA) quarterly data. Downloaded 2026-09-22. This is not an official register extract — see ariregister.rik.ee.

Company data on this site is available under CC BY-SA 4.0.

To request a correction or the removal of this page, use the contact form. Removal requests are handled within 30 days, no justification required.